Adient (ADNT) Cash & Equivalents (2015 - 2026)

Adient (ADNT) has 12 years of Cash & Equivalents data on file, last reported at $831.0 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents rose 10.21% year-over-year to $831.0 million; the trailing twelve-month figure through Mar 2026 stood at $831.0 million (up 10.21% YoY), and the FY2025 full-year result was $958.0 million, up 1.38% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $831.0 million, down from $855.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $1.1 billion in Q1 2022 and bottomed at $754.0 million in Q1 2025.
• The 5-year median for Cash & Equivalents is $901.0 million (2022), against an average of $914.7 million.
• The widest annual swing landed in 2022, when Cash & Equivalents plunged 56.68%; it then advanced 17.21% in 2023.
• A 5-year view of Cash & Equivalents shows it stood at $901.0 million in 2022, then rose by 9.88% to $990.0 million in 2023, then retreated by 13.13% to $860.0 million in 2024, then slipped by 0.58% to $855.0 million in 2025, then decreased by 2.81% to $831.0 million in 2026.
• The last three Cash & Equivalents figures came in at $831.0 million (Q1 2026), $855.0 million (Q4 2025), and $958.0 million (Q3 2025), per Business Quant data.

Peer Comparison